端到端制造的通用数字控制概念

IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY
L. Kuchler , A. Azimi , H. Damiri , S. Martinuzzi , M. Steinberger , J. Rehrl , J. Poms , M. Kureck , D. Kirschneck , M. Horn , J. Khinast , S. Sacher
{"title":"端到端制造的通用数字控制概念","authors":"L. Kuchler ,&nbsp;A. Azimi ,&nbsp;H. Damiri ,&nbsp;S. Martinuzzi ,&nbsp;M. Steinberger ,&nbsp;J. Rehrl ,&nbsp;J. Poms ,&nbsp;M. Kureck ,&nbsp;D. Kirschneck ,&nbsp;M. Horn ,&nbsp;J. Khinast ,&nbsp;S. Sacher","doi":"10.1016/j.ijpharm.2025.125599","DOIUrl":null,"url":null,"abstract":"<div><div>With the implementation of advanced manufacturing concepts (e.g., continuous operation, integration of different process routes and modular manufacturing), control of the process and the related product quality becomes more complex. Unlike traditional in-process controls and end-product testing, modern high-speed manufacturing does not allow for delays due to measurements between unit operations and requires real-time information about the material state and associated control actions. This study presents a universally applicable control concept, which offers the highest level of control together with flexibility for processing, equipment and automation. The concept can deal with a combination of batch and continuously operated process steps, manual and automated operation, different scales of equipment, and digital and manual data acquisition. It was demonstrated using a compact end-to-end manufacturing line for tablets, which included the active pharmaceutical ingredient (API) synthesis, crystallization, filtration and washing, as well as the formulation part. A suspension of API was directly fed into hot melt extrusion (HME), which was combined with direct compaction (DC). The control strategy was based on data not only from classical process analytical technology (PAT) sensors, but also from the equipment and soft sensors (e.g., the content was monitored and controlled using the soft sensors and the feeder data). The process and quality information were fed into a digital twin of the entire process, which executed the model-based control strategy.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"676 ","pages":"Article 125599"},"PeriodicalIF":5.3000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A universal digital control concept for end-to-end manufacturing\",\"authors\":\"L. Kuchler ,&nbsp;A. Azimi ,&nbsp;H. Damiri ,&nbsp;S. Martinuzzi ,&nbsp;M. Steinberger ,&nbsp;J. Rehrl ,&nbsp;J. Poms ,&nbsp;M. Kureck ,&nbsp;D. Kirschneck ,&nbsp;M. Horn ,&nbsp;J. Khinast ,&nbsp;S. Sacher\",\"doi\":\"10.1016/j.ijpharm.2025.125599\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>With the implementation of advanced manufacturing concepts (e.g., continuous operation, integration of different process routes and modular manufacturing), control of the process and the related product quality becomes more complex. Unlike traditional in-process controls and end-product testing, modern high-speed manufacturing does not allow for delays due to measurements between unit operations and requires real-time information about the material state and associated control actions. This study presents a universally applicable control concept, which offers the highest level of control together with flexibility for processing, equipment and automation. The concept can deal with a combination of batch and continuously operated process steps, manual and automated operation, different scales of equipment, and digital and manual data acquisition. It was demonstrated using a compact end-to-end manufacturing line for tablets, which included the active pharmaceutical ingredient (API) synthesis, crystallization, filtration and washing, as well as the formulation part. A suspension of API was directly fed into hot melt extrusion (HME), which was combined with direct compaction (DC). The control strategy was based on data not only from classical process analytical technology (PAT) sensors, but also from the equipment and soft sensors (e.g., the content was monitored and controlled using the soft sensors and the feeder data). The process and quality information were fed into a digital twin of the entire process, which executed the model-based control strategy.</div></div>\",\"PeriodicalId\":14187,\"journal\":{\"name\":\"International Journal of Pharmaceutics\",\"volume\":\"676 \",\"pages\":\"Article 125599\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378517325004363\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325004363","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

随着先进制造理念(如连续作业、不同工艺路线的集成和模块化制造)的实施,工艺控制和相关产品质量变得更加复杂。与传统的过程控制和最终产品测试不同,现代高速制造不允许由于单元操作之间的测量而造成延迟,并且需要有关材料状态和相关控制动作的实时信息。本研究提出了一种普遍适用的控制概念,它提供了最高水平的控制以及加工,设备和自动化的灵活性。该概念可以处理批量和连续操作的工艺步骤,手动和自动化操作,不同规模的设备以及数字和手动数据采集的组合。使用紧凑的端到端片剂生产线进行演示,包括活性药物成分(API)合成,结晶,过滤和洗涤以及配方部分。将原料药悬浮液直接注入热熔挤压(HME)中,并与直接压实(DC)相结合。该控制策略不仅基于经典过程分析技术(PAT)传感器的数据,还基于设备和软传感器的数据(例如,使用软传感器和给料器数据对内容进行监测和控制)。将过程和质量信息输入到整个过程的数字孪生体中,执行基于模型的控制策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A universal digital control concept for end-to-end manufacturing

A universal digital control concept for end-to-end manufacturing
With the implementation of advanced manufacturing concepts (e.g., continuous operation, integration of different process routes and modular manufacturing), control of the process and the related product quality becomes more complex. Unlike traditional in-process controls and end-product testing, modern high-speed manufacturing does not allow for delays due to measurements between unit operations and requires real-time information about the material state and associated control actions. This study presents a universally applicable control concept, which offers the highest level of control together with flexibility for processing, equipment and automation. The concept can deal with a combination of batch and continuously operated process steps, manual and automated operation, different scales of equipment, and digital and manual data acquisition. It was demonstrated using a compact end-to-end manufacturing line for tablets, which included the active pharmaceutical ingredient (API) synthesis, crystallization, filtration and washing, as well as the formulation part. A suspension of API was directly fed into hot melt extrusion (HME), which was combined with direct compaction (DC). The control strategy was based on data not only from classical process analytical technology (PAT) sensors, but also from the equipment and soft sensors (e.g., the content was monitored and controlled using the soft sensors and the feeder data). The process and quality information were fed into a digital twin of the entire process, which executed the model-based control strategy.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.70
自引率
8.60%
发文量
951
审稿时长
72 days
期刊介绍: The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信